LORAZEPAM - A RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY OF A NEW ANTIEMETIC IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY AND PROCHLORPERAZINE

被引：60

作者：

BISHOP, JF ^{[1
]}

OLVER, IN ^{[1
]}

WOLF, MM ^{[1
]}

MATTHEWS, JP ^{[1
]}

LONG, M ^{[1
]}

BINGHAM, J ^{[1
]}

HILLCOAT, BL ^{[1
]}

COOPER, IA ^{[1
]}

机构：

[1] PETER MACCALLUM HOSP,MELBOURNE,AUSTRALIA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 06期

关键词：

D O I：

10.1200/JCO.1984.2.6.691

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：691 / 695

页数：5

共 11 条

[1] PHARMACOKINETICS OF 2 LORAZEPAM FORMULATIONS, ORAL AND SUBLINGUAL, AFTER MULTIPLE DOSES [J].

CAILLE, G ;

SPENARD, J ;

LACASSE, Y ;

BRENNAN, J .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1983, 4 (01) :31-42

[2] COMPARISON OF THE ACTIONS OF DIAZEPAM AND LORAZEPAM [J].

DUNDEE, JW ;

MCGOWAN, WAW ;

LILBURN, JK ;

MCKAY, AC ;

HEGARTY, JE .

BRITISH JOURNAL OF ANAESTHESIA, 1979, 51 (05) :439-446

[3]

ELLIOTT HW, 1971, CLIN PHARMACOL THER, V12, P468

[4] LORAZEPAM AS AN ADJUNCT TO ANTI-EMETIC THERAPY WITH HALOPERIDOL IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY [J].

FRIEDLANDER, ML ;

KEARSLEY, JH ;

SIMS, K ;

COATES, A ;

HEDLEY, D ;

RAGHAVAN, D ;

FOX, RM ;

TATTERSALL, MHN .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1983, 13 (01) :53-56

[5]

FRYTAK S, 1981, JAMA, V245, P383

[6]

LASZLO J, 1983, P AN M AM SOC CLIN, V2, P95

[7]

MEUR MN, 1983, P AM SOC CLIN ONCOL, V2, P88

[8]

PEROUTKA, 1982, LANCET, V1, P658

[9] MEASURING THE QUALITY OF LIFE OF CANCER-PATIENTS - A CONCISE QL-INDEX FOR USE BY PHYSICIANS [J].

SPITZER, WO ;

DOBSON, AJ ;

HALL, J ;

CHESTERMAN, E ;

LEVI, J ;

SHEPHERD, R ;

BATTISTA, RN ;

CATCHLOVE, BR .

JOURNAL OF CHRONIC DISEASES, 1981, 34 (12) :585-597

[10] LORAZEPAM AS NIGHT SEDATION AND PREMEDICATION - COMPARISON WITH DIAZEPAM [J].

STUDD, C ;

ELTRINGHAM, RJ .

ANAESTHESIA, 1980, 35 (01) :60-64

← 1 2 →